39
Leadership team at Portal Biotech, from the left to the right: Tim Massingham (VP ML & Bioinformatics), Andrew Heron (Co-Founder & CEO), Giovanni Maglia (Co-Founder & CSO) and Selly Saini (COO). Photography credits: Panji Kaonga
Portal Biotech Closes $35M Series A to Deliver First Full-Length Single-Molecule Protein Sequencer.
Breakthrough proteomics platform technology unlocks full-length protein sequencing and characterisation, accelerating drug development & diagnostics. tinyurl.com/5y9cjbej #proteomics #nanopore
02.07.2025 16:48 — 👍 5 🔁 4 💬 0 📌 0
“The most important applications of protein sequencing will be the ones we have no idea about today”
Giovanni Maglia reflects on the future of next-generation proteomics and the challenges of de novo protein sequencing
“The most important applications of protein sequencing will be the ones we have no idea about today”. Giovanni Maglia founder of Portal Biotech and keynote speaker of #RNGS25, during a chat with our flying reporter Sarah Geurs, Technology Expert at the VIB Tech Watch Core! prez.ly/Zmid
02.04.2025 12:00 — 👍 1 🔁 2 💬 1 📌 0
